ReviewFrontiers in oncology2021

Mechanisms and Implications of CDK4/6 Inhibitors for the Treatment of NSCLC.

Jinmeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.